Preclinical assessment of the GluN2B inhibitor clinical candidate NP10679 as a medication to prevent opiate abuse relapse

Project: Research project

StatusActive
Effective start/end date7/15/186/30/20

Funding

  • HHS: National Institutes of Health (NIH): $94,841.00